Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yemi Oluboyede

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Health Technology Assessment (Winchester, England)|March 3, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm studyAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Trials|June 5, 2016
Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trialCatherine Brennand, Alexander von Wilamowitz-Moellendorff, Sarah Dunn, et al.
Health Technology Assessment (Winchester, England)|May 17, 2018
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCTRobert Pickard, Thomas Chadwick, Yemi Oluboyede, et al.
Health Technology Assessment (Winchester, England)|March 13, 2024
Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCTSean Carrie, Tony Fouweather, Tara Homer, et al.
BMJ (Clinical Research Ed.)|October 18, 2023
Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trialSean Carrie, James O'Hara, Tony Fouweather, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Health Technology Assessment (Winchester, England)|March 3, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm studyAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Trials|June 5, 2016
Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trialCatherine Brennand, Alexander von Wilamowitz-Moellendorff, Sarah Dunn, et al.
Health Technology Assessment (Winchester, England)|May 17, 2018
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCTRobert Pickard, Thomas Chadwick, Yemi Oluboyede, et al.
Health Technology Assessment (Winchester, England)|March 13, 2024
Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCTSean Carrie, Tony Fouweather, Tara Homer, et al.
BMJ (Clinical Research Ed.)|October 18, 2023
Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trialSean Carrie, James O'Hara, Tony Fouweather, et al.
Pageof 5